BUSINESS - Page 37

Newsmeter brings you latest business news that includes India and world Economics, Finance, Stock Markets, IPO, Banking and Industrial Monetary & Trade Policies, BSE & NSC news
Complex  manufacturing process, cost of raw materials behind Covaxin cost: Bharat Biotech
Complex manufacturing process, cost of raw materials behind Covaxin cost: Bharat Biotech

The supply price of Covaxin at Rs 150 per dose to the government of India is a non-competitive price and clearly not sustainable in the long run....

By Newsmeter Network  Published on 15 Jun 2021 4:01 PM IST


CSIR, Laxai Life Sciences get nod to conduct clinical trials of colchicine on COVID-19 patients
CSIR, Laxai Life Sciences get nod to conduct clinical trials of colchicine on COVID-19 patients

The partner CSIR institutes in this clinical trial are the CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad, and the CSIR-Indian...

By Newsmeter Network  Published on 12 Jun 2021 4:59 PM IST


Hyderabad: IICT, Lee Pharma sign deal for 2-DG synthesis to treat COVID patients
Hyderabad: IICT, Lee Pharma sign deal for 2-DG synthesis to treat COVID patients

IICT is a constituent laboratory of CSIR and Lee Pharma, an integrated pharmaceutical company, based in Hyderabad.

By Newsmeter Network  Published on 10 Jun 2021 9:51 AM IST


Amphotericin B Emulsion: Hyderabad-based Celon Laboratories launch anti- black fungus drug; price Rs 4,250
'Amphotericin B Emulsion': Hyderabad-based Celon Laboratories launch anti- black fungus drug; price Rs 4,250

Hyderabad-based Celon Laboratories has announced the launch of 'Amphotericin B Emulsion' an alternative drug for the treatment of Mucormycosis...

By Newsmeter Network  Published on 5 Jun 2021 9:55 AM IST


`Blame it on the fish: Indias seafood exports drop by 10.88%, thanks to COVID
`Blame it on the fish': India's seafood exports drop by 10.88%, thanks to COVID

In 2019-20, India exported 12,89,651 MT of seafood worth Rs. 46,662.85 crore (US$ 6.68 billion), marking a decline of 6.31 per cent in rupee terms and...

By Newsmeter Network  Published on 4 Jun 2021 6:45 AM IST


Ocugen expands Covaxin commercialization rights to include Canada
Ocugen expands Covaxin commercialization rights to include Canada

Ocugen’s existing rights to commercialize Covaxin was in the United States.

By Newsmeter Network  Published on 3 Jun 2021 6:01 PM IST


Centre pre-books 30 crore doses of Hyderabad-based Biological-Es under trial vaccine
Centre pre-books 30 crore doses of Hyderabad-based Biological-E's under trial vaccine

It will be the second made-in-India vaccine to be used in the country after Bharat Biotech's Covaxin.

By Newsmeter Network  Published on 3 Jun 2021 10:36 AM IST


Meril Diagnostics to manufacture kits for CCMB dry swab tests
Meril Diagnostics to manufacture kits for CCMB dry swab tests

Cellular and Molecular Biology has developed a dry swab-based direct RT-PCR, and has tied up with Meril diagnostics, for commercially scaling up the...

By Newsmeter Network  Published on 2 Jun 2021 11:46 PM IST


Hyderabads IIL to supply stock to Bharat Biotech for production of Covaxin
Hyderabad's IIL to supply stock to Bharat Biotech for production of Covaxin

In a bid to augment vaccine production, the government has decided to support some public sector companies with grants under the Mission COVID...

By Newsmeter Network  Published on 29 May 2021 9:02 AM IST


WHO approval for `Covaxin expected by July-Sep: Bharat Biotech
WHO approval for `Covaxin' expected by July-Sep: Bharat Biotech

Bharat Biotech on Tuesday said the company has approached World Health Organization (WHO) for Emergency Use Listing (EUL) of `Covaxin’ and they expect...

By Newsmeter Network  Published on 26 May 2021 10:00 AM IST


`More information required: WHO asks Bharat Biotech before approving `Covaxin
`More information required': WHO asks Bharat Biotech before approving `Covaxin'

World Health Organization (WHO) has said more information is required from Bharat Biotech before approving the emergency use listing (EUL) of...

By Newsmeter Network  Published on 25 May 2021 11:01 AM IST


Vaccine shortage: Hyderabad-based Bharat Biotech to produce 200M `Covaxin doses at Gujarat facility
Vaccine shortage: Hyderabad-based Bharat Biotech to produce 200M `Covaxin' doses at Gujarat facility

Bharat Biotech on Thursday announced to produce 200 million doses of `Covaxin' per annum at its Gujarat facility to ramp up supplies in the country.

By Newsmeter Network  Published on 21 May 2021 12:16 PM IST


Share it